皮肤溶解-布洛萨相关状细胞癌支持免疫抑制瘤微环境:免疫疗法的前景
David Rafei-Shamsabadi1, Lena Scholten1, Sisi Lu1,2
1Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, 79104 Freiburg, Germany.
Cancers
|January 26, 2024
概括
皮肤状细胞癌 (SCCs) 在表皮溶解牛 (EB) 显示增加的免疫抵抗标记物,如胺二氧化酶 (IDO) 和编程细胞死亡-1 (PD-L1). 这些发现表明EB-SCCs的潜在新治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤状细胞癌 (SCC) 是表皮溶解牛皮细胞 (EB) 的严重并发症,特别是在变质EB (DEB) 和KindlerEB (KEB) 亚型中.
- 免疫抑制 (IS) 患者也表现出高发病率的攻击性SCCs,往往在移植后.
- 了解EB-SCC中的免疫抵抗机制对于开发有效疗法至关重要.
研究的目的:
- 研究EB相关SCC中免疫检查点蛋白和免疫抑制酶的表达.
- 为了将这些表达模式与来自免疫抑制 (IS) 和免疫能力 (IC) 个人的SCC进行比较.
- 确定EB-SCCs的潜在治疗点.
主要方法:
- 使用免疫组织化学和半定量分析来评估蛋白质表达.
- 这项研究分析了氨酸2,3-二氧化酶 (IDO),PD-1,PD-L1,TIM-3,LAG-3和炎症透物 (CD4,CD8,CD68).
- 样本包括30个DEB-SCC,22个KEB-SCC,106个IS-SCC和100个IC-SCC.
主要成果:
- 与IC和IS SCC相比,DEB-SCC的IDO,PD-L1和PD-1水平显著更高.
- 在DEB-SCCs和IC-SCCs中观察到的CD4+ T细胞数量较少.
- 在KEB-SCC中,疲劳标记TIM-3和LAG-3表现最低.
结论:
- 在EB-SCC中增加的IDO,PD-1和PD-L1表达表明免疫抵抗.
- 这些标记物,特别是在DEB-SCC中,代表了组合疗法的有希望的目标.
- 需要进一步的研究来探索EB相关的SCCs的新型治疗策略.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:30Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
01:12Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K